Moderna executives offloaded nearly $30 million of stocks a day after unveiling coronavirus vaccine  Daily MailView Full coverage on Google News
Moderna's share price skyrocketed after it released promising results from its vaccine trial Monday, sparking hope that a vaccine could be available January.Moderna's share price skyrocketed after it released promising results from its vaccine trial Monday, sparking hope that a vaccine could be available January.

Moderna executives offloaded nearly $30 million of stocks a day after unveiling coronavirus vaccine | Daily Mail Online

The project will compress what is typically 10 years of vaccine development and testing into a matter of months.The project will compress what is typically 10 years of vaccine development and testing into a matter of months.

US plans massive coronavirus vaccine testing effort to meet year-end deadline - World - DAWN.COM

Bloomberg - Are you a robot?

We may be harder to persuade than we were in the polio vaccine days.We may be harder to persuade than we were in the polio vaccine days.

Column: When we have a coronavirus vaccine, will we want to use it? - Chicago Tribune

Will vaccine for COVID-19 play into the developing narrative of seeing a shift of technological and scientific innovation from the Global North to the Global South? Or will the race simply re-instate the Cold War notion of Western world dominance?Will COVID vaccine shift narrative in technological & scientific innovation from Global North to Global South? 

Will India Overtake China As Global Power If It Wins the Vaccine Race? | OPINION

The speed in developing vaccines for widespread testing this summer is impressive, but running trials involving tens of thousands of people will be an immense undertaking.The speed in developing vaccines so far is impressive, but running trials this summer involving tens of thousands of people will be a tough challenge.

Op-Ed: Fast coronavirus vaccine could bring problems - Los Angeles Times

If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.If there is a silver lining to the flawed U.S. response to the coronavirus pandemic, it is this: The relatively high number of new cases being diagnosed daily — upward of 20,000 — will make it easier to test new vaccines.

Analysis: Get ready for the vaccine — they’re never simple

“A question for SEC insider trading investigators is whether any investors benefited from information unavailable publicly. All of us want effective COVID-19 vaccines ASAP. Illegal profiteering may actually impede that goal. https://t.co/AdLdVhzr2T”

Richard Blumenthal on Twitter: "A question for SEC insider trading investigators is whether any investors benefited from information unavailable publicly. All of us want effective COVID-19 vaccines ASAP. Illegal profiteering may actually impede that goal. https://t.co/AdLdVhzr2T"

“#COVID19 ⁦@UniofOxford⁩ vaccine trial has only 50 per cent chance of success, says project leader. #coronavirus https://t.co/bwNUOBQjcD”

Steve Herman on Twitter: "#COVID19 ⁦@UniofOxford⁩ vaccine trial has only 50 per cent chance of success, says project leader. #coronavirus https://t.co/bwNUOBQjcD"

“Podcast with Head of the Sidhu Lab at U of T, Sachdev Sidhu drops Monday. Incredible information on the Virus and a 'Cure' VS a vaccine. Help is on the way. bhttps://deanblundell.com/news/toronto-researcher-has-found-the-cure-for-covid19/”

Dean Blundell on Twitter: "Podcast with Head of the Sidhu Lab at U of T, Sachdev Sidhu drops Monday. Incredible information on the Virus and a 'Cure' VS a vaccine. Help is on the way. bhttps://deanblundell.com/news/toronto-researcher-has-found-the-cure-for-covid19/"

““Manufacturing is not the hurdle. Its taking the time to collect enough efficacy & safety data”. The Operation Warp Speed language [saying] “that they will have a vaccine by the fall — or in weeks or days — does so much damage.” ⁦⁦@PeterHotez #covid19 https://t.co/Kopzt4Nc1F”

Professor Senait Fisseha on Twitter: "“Manufacturing is not the hurdle. Its taking the time to collect enough efficacy & safety data”. The Operation Warp Speed language [saying] “that they will have a vaccine by the fall — or in weeks or days — does so much damage.” ⁦⁦@PeterHotez #covid19 https://t.co/Kopzt4Nc1F"

The top White House aide argued the media's coverage of President Trump's handling of the coronavirus could be the reason behind his declining poll numbers.

'Maybe the media don't cover it fairly': Kellyanne Conway says media to blame for Trump coronavirus poll numbers

Reuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end. By Adam ButtonReuters report on the vaccine trial The US plans a massive round of phase 2 vaccine trials in an effort to speed up the timeline for vaccine development to have a mass candidate ready by year-end.

US will test vaccines on more than 100,000 people starting in July - report

The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.

Moderna has seen its market cap increase from $9 billion to over $25 billion in the past two months. While it may be justified due to its Covid-19 trails, a lot has to go right to justify its stratospheric valuation.Moderna has seen its market cap increase from $9 billion to over $25 billion in the past two months. While it may be justified due to its Covid-19 trails, a lot has to go right to justify its stratospheric valuation.

Buyer Beware: Covid-19 Vaccine Maker Moderna Is Valued In The Stratosphere

Moderna’s initial coronavirus vaccine results are promising -- but confirmation in more trial participants is key.Moderna’s initial coronavirus vaccine results are promising -- but confirmation in more trial participants is key.

Moderna Shares Surged 20% on Coronavirus Vaccine Data. Here's What May Drive Them Higher. | The Motley Fool

In a recent poll by Reuters and Ipsos, 1 out of 4 of Americans had little or no interest in a COVID-19 vaccine. Fears stem from 'Operation Warp Speed' sacrificing safety for speed. 'Many experts believe a fully tested, government-approved vaccine will not be widely available until mid-2021 at the earliest.'

Americans express fears surrounding a COVID-19 vaccine | World Economic Forum

The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...The United States plans a massive testing effort involving more than 100,000 volunteers and a half dozen or so of the most promising vaccine ...

US plans massive COVID-19 vaccine testing effort to meet year-end deadline - CNA

Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.

7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine | InvestorPlace

Dr. Anthony Fauci said that he's "cautiously optimistic" about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is one of Moderna's partners on the COVID-19 drug, but the agency has been quiet this week on the heels of Moderna's ...Dr. Anthony Fauci said that he’s “cautiously optimistic” about the coronavirus vaccine Moderna is working on. The National Institute of Allergy and Infectious Diseases (NIAID) is …

Dr. Fauci has some good news about a coronavirus vaccine – BGR

Austin's own Tito's Handmade Vodka has provided a million-dollar grant to Baylor College of Medicine as they work to research a vaccine for COVID-19.Austin's own Tito's Handmade Vodka has provided a million-dollar grant to Baylor College of Medicine as they work to research a vaccine for COVID-19.

Tito's Handmade Vodka gives $1 million for COVID-19 vaccine research | WBNS-10TV Columbus, Ohio | Columbus News, Weather & Sports

Vaccine goal tailor-made for China's biotech firms - World - Chinadaily.com.cn

As the coronavirus (COVID-19) pandemic continues ravaging the globe, the search for a vaccine against the novel infectious disease has become the primary concern for...As the coronavirus (COVID-19) pandemic continues ravaging the globe, the search for a vaccine against the novel infectious disease has become the primary concern for...

US Top Health Expert Fauci Explains Risks Behind Development of COVID-19 Vaccine - Sputnik International

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute millions of doses as the year comes to a close.The nation's top infectious disease expert said Friday that an aggressive investment into the development and production of a vaccine against the coronavirus might make it possible to distribute

The Hill interview: Fauci on why a vaccine by end of year is 'aspirational' | TheHill

A new poll from Reuters and Ipsos has found that a quarter of Americans weren't interested in taking a Covid-19 vaccine, which doesn't even exist.Covid-19 has wreaked havoc on the world, causing 5 million recorded infections and 333,000 deaths so far, with a third of the world under lockdown. In orde

A Quarter Of Americans Are Hesitant About Taking A Covid-19 Vaccine That Doesn't Yet Exist | IFLScience

Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall.

The Coronavirus Vaccine Is on Track to Be the Fastest Ever Developed | The New Yorker

404 Not Found

Today's Covid-19 developments include news about a New Zealand vaccine venture, a lauded celebrity cat, problems getting shearing gangs, and a warning against Trump's favoured medicine of choice.Today's Covid-19 developments include news about a New Zealand vaccine venture, a lauded celebrity cat, problems getting shearing gangs, and a warning against Trump's favoured medicine of choice.

Covid-19: What happened in NZ and around the world on 23 May | RNZ News

With massive disruptions to global immunisation programmes, experts fear that the developing world will not be able to get COVID-19 vaccine even once its ready.With massive disruptions to global immunisation programmes, experts fear that the developing world will not be able to get COVID-19 vaccine even once its ready.

COVID-19: Experts fear much of developing world may not get a vaccine even once its ready - Republic World

BANGKOK - Thailand on Saturday began testing a vaccine against the coronavirus on monkeys after positive trials in mice, an official said.BANGKOK - Thailand on Saturday began testing a vaccine against the coronavirus on monkeys after positive trials in mice, an official said.

Coronavirus vaccine: Thailand begins COVID-19 vaccine trials on monkeys - Times of India

Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.Vincent Chen wrote that it was “hard to pick winners” among the many Covid-19 vaccine programs, and that a vaccine wouldn’t be widely available until later next year.

A Covid-19 Vaccine Could Be Ready Late This Year, Bernstein Analyst Says - Barron's

An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response. A study published Friday in the Lancet says the formulation from China’s CanSino Biologics Inc. needs more trials to determine whether it can actually protect against SARS-CoV-2, […]

Early results promising for potential COVID-19 vaccine to be tested on Canadians - CityNews Toronto

As Moderna reported encouraging news on a vaccine trial, top executives moved their stock.As Moderna reported encouraging news on a vaccine trial, top executives moved their stock.

Modern execs sell stock amid coronavirus vaccine news - New York Daily News

Hello, Welcome to Dispensed, Business Insider's weekly healthcare newsletter. We've made it to Memorial Day weekend! Hope everyone's found a restful way toWelcome to Dispensed. Inside, how the pandemic has transformed the drug industry and how hospitals handle future surges of patients.

Dispensed: Vaccine updates — Coronavirus medical bills — COVID-19 skin complications | Business Insider India

Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.Four of the biotech's top executives netted a total of $30 million since positive results for a coronavirus vaccine were touted.

Moderna CEO and other execs made millions on vaccine announcement - CBS News

Vaccines will be tested in healthcare workers and communities where the virus is still spreading to show whether they reduced new cases of Covid-19.Vaccines will be tested in healthcare workers and communities where the virus is still spreading to show whether they reduced new cases of Covid-19.

Covid-19: US plans massive coronavirus vaccine testing effort to meet year-end deadline - News | Khaleej Times

Donald Trump's approval rating for his coronavirus response continues to fall, with just 39% of Americans approving of his handling of the deadly virus,Just 39% of Americans approve of Trump's coronavirus response, down from a high of 55% in March.

Trump's approval rating on coronavirus response hits new low

Donald Trump's approval rating for his coronavirus response continues to fall, with just 39% of Americans approving of his handling of the deadly virus,

NoCookies | The Australian

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

Hydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to everyone in the country | The virus’s strangest symptoms are just emerging | On Memorial Day weekend, neighboring beach towns tell New Yorkers to stay away | Will the pandemic foreverHydroxychloroquine linked to increased death in COVID-19 patients | Fauci says it’s ‘conceivable’ that US could have vaccine by December | Biden says he would make a coronavirus vaccine free to

The Hill's Coronavirus Report: Surgeon General stresses need to invest much more in public health infrastructure, during and after COVID-19; Fauci hopeful vaccine could be deployed in December | TheHill

China Has Vaccine Using Cold Virus With Some ResultsA Chinese vaccine for COVID-19 showed promising results in a Stage 1 clinical trial, producing immune calls called T calls within two weeks, The New York Times reported."This is promising data, but it's early data," a Boston vaccine research director, Dr. Dan Barouch, not...

China Has Vaccine Using Cold Virus With Some Results | Newsmax.com

Anthony Fauci told mayors and city leaders at a seminar hosted at Harvard Kennedy School that they should “expect” to see new “blips of infections” as communities begin to reopen, but not to be “discouraged.” Anthony Fauci told mayors and city leaders at a seminar hosted at Harvard Kennedy School that they should “expect” to see new “blips of infections” as communities begin to reopen, but not to be “discouraged.”

Fauci offers candid advice to city leaders at virtual gathering – Harvard Gazette

Fox News' Martha MacCallum pressed White House counselor Kellyanne Conway Friday about polling showing a majority disapproving of President Donald Trump'sFox News' Martha MacCallum pressed White House counselor Kellyanne Conway Friday about polling showing a majority disapproving of President Donald Trump's handling of the coronavirus pandemi

Martha MacCallum Presses Kellyanne Conway on Trump Polling

In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka. <p>In this week’s interview, Dr. Peter Hotez discusses his alarm that the Houston area doesn’t yet have the public-health troops it needs to reopen, his worries about the anti-vaccine movement, and a surprising new funder of his research — Tito’s Vodka.</p>

Vaccine expert Peter Hotez reveals 3 things to help Houston reopen, avoid second surge of COVID-19 - HoustonChronicle.com

A coronavirus vaccine might be the door out of this hell. What if our neighbors refuse to walk through it?As the COVID-19 pandemic has unwound around the world and in North Texas, there's been a pot of gold at the end of the rainbow. The only surefire way out of our new confines, according to epidemiologists and public health officials, is researchers finding a vaccine for the novel coronavirus...

What If Texans Won't Get a Coronavirus Vaccine? | Dallas Observer